Institute of Good Manufacturing Practices India®

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

Bi-Flow cannula introduced by LivaNova to prevent limb ischemia

17th July 2019

LivaNova, UK-based medical technology firm, has introduced the CE-Marked Bi-Flow arterial femoral cannula intended for the prevention of leg ischemia during cardiac surgery.

It is designed as a bidirectional cannula and features a shoulder and downstream perfusion channel to ensure continuous blood flow down the femoral artery. It offers simultaneous systemic and distal perfusion of the cannulated limb. Its open tip design allows adequate systemic perfusion through the whole body.

Leg ischemia develops due to abnormal blood flow to a lower limb and it affects up to 11% patients receiving complex cardiac surgery procedures. This can even lead to higher mortality and morbidity, and longer hospital stays.

In a clinical study it was reported that the new Bi-Flow cannula facilitate easy insertion and removal without any complications. Safe and reproducible perfusion of the limb was also observed with it.

First European procedure using this cannula was performed at the Cardiovascular Center of Bad Neustadt, Germany.

Currently, it is available in markets like European and Canada and is under pre-market notification for the US.

LivaNova plans the expansion of the cannula from existing 19fr size to additional sizes.

For further enquiries, write to or call us on: +91 8587838177, +91 8130924488, 0120-2427175, 0120-4375280

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like